“Patient iPSC models reveal glia-intrinsic phenotypes in multiple sclerosis.” Benjamin L. L. Clayton, et al. – Case Western Reserve...
Featured Preprints
“Alzheimer’s disease linked Aβ42 exerts product feedback inhibition on γsecretase impairing downstream cell signaling.” Katarzyna Marta Zoltowska, et al....
“A Familial Alzheimer’s Disease Associated Mutation in Presenilin-1 Mediates Amyloid-Beta Independent Cell Specific Neurodegeneration.” Mahraz Parvand, et al. –...
“Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer’s disease.” Gemma Salvadó, et al. –...
“Combination-Based Drug Screening for Induced Oligodendrocyte Differentiation Enables Mechanistic Insight and Identifies Optimal Drug Pairs for Remyelination.” Brittney A. Beyer,...
“Deleterious functional consequences of perfluoroalkyl substances accumulation into the myelin sheath.” L. Butruille, et al. – Sorbonne University. This...
“Functional variations in gamma-secretase activity are critical determinants of the clinical, biomarker, and cognitive progression of autosomal dominant Alzheimer’s...
“Identification of commensal gut microbiota signatures as predictors of clinical severity and disease progression in multiple sclerosis.” Theresa L....
“The MIND diet, brain transcriptomic alterations, and dementia.” Jun Li, et al. – Brigham and Women’s Hospital. “Therapeutic potential...
“Syndecan-1 as specific cerebrospinal fluid biomarker of multiple sclerosis.” Geoffrey Hinsinger, et al. – Université de Montpellier. To find...